PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 50 filers reported holding PASSAGE BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,263,528 | -30.1% | 4,959,769 | 0.0% | 1.74% | -68.7% |
| Q2 2023 | $4,668,631 | -1.7% | 4,959,769 | 0.0% | 5.54% | -44.1% |
| Q1 2023 | $4,749,971 | -30.6% | 4,959,769 | 0.0% | 9.90% | -30.1% |
| Q4 2022 | $6,844,481 | +10.4% | 4,959,769 | 0.0% | 14.16% | +34.0% |
| Q3 2022 | $6,200,000 | -47.0% | 4,959,769 | 0.0% | 10.57% | -41.1% |
| Q2 2022 | $11,705,000 | -23.9% | 4,959,769 | 0.0% | 17.94% | +16.9% |
| Q1 2022 | $15,375,000 | -51.2% | 4,959,769 | 0.0% | 15.35% | -8.9% |
| Q4 2021 | $31,495,000 | -36.2% | 4,959,769 | 0.0% | 16.84% | -17.6% |
| Q3 2021 | $49,399,000 | -24.8% | 4,959,769 | 0.0% | 20.45% | -6.0% |
| Q2 2021 | $65,667,000 | -24.3% | 4,959,769 | 0.0% | 21.76% | +28.8% |
| Q1 2021 | $86,697,000 | – | 4,959,769 | – | 16.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1,648,629 | 2.12% |
| Versant Venture Management, LLC | 4,959,769 | $3,263,528 | 1.74% |
| BML Capital Management, LLC | 2,058,767 | $1,354,669 | 1.24% |
| Acuitas Investments, LLC | 418,161 | $275,150 | 0.16% |
| Orbimed Advisors | 10,124,576 | $6,661,971 | 0.14% |
| Lynx1 Capital Management LP | 190,124 | $125,102 | 0.08% |
| Frazier Life Sciences Management, L.P. | 1,758,219 | $1,156,908 | 0.08% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $263,200 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $56,621 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 506,600 | $333,343 | 0.01% |